Updates

Made Tech

February 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Made’s recovery continues and notwithstanding H1 sales, which were down from £20.6m to £19.1m, adjusted EBITDA improved threefold from £0.5m to £1.4m, for a margin of 7% up from 2%. Made said this is all in line with management expectations helped by an increase in billable utilisation, a reduction of contractor numbers and targeted headcount reductions. The market for new wins "remains subdued” but the contracted backlog of £61.3m, whilst down slightly from the record of £67.9m six months earlier, is well up on £47.8m a year ago. Three big contracts worth £10.7m (Department for Business and Trade, Government Digital Service and Ministry of Justice) were won in H1. The way the share price reacted to an in-line statement is a bit surprisi ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Nexteq

Inspecs

Made Tech (May 2024)

Made Tech (August 2023)

Made Tech - Record order book but government slow to start contracts (May 2023)

Made Tech (March 2023)

Made Tech (February 2023)

Made Tech (December 2022)

Made Tech - Headcount rockets from 235 to 478 (September 2022)

Made Tech Group - Son of Kainos (January 2022)

Matchtech - Engineering recruiter sees good momentum (February 2013)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X